Leadership Team
Craig Deligdish, MD
Founder and President
Craig Deligdish attended college at Johns Hopkins University and graduated from the New York University School of Medicine. He completed research at the National Cancer Institute, as a member of the Public Health Service before going on to complete an internship and residency at Parkland Memorial Hospital, the Dallas Veterans Administration Medical Center and the University of Texas Southwestern Medical School in Dallas, Texas. Dr. Deligdish completed fellowships in hematology and medical oncology at the Dana Farber Cancer Institute, the Brigham and Women’s Hospital and Harvard Medical School. He has served on the faculty of University of Texas Southwestern Medical School and Harvard Medical School. At the University of Texas Southwestern, Dr. Deligdish served as the Chief of the General Medicine Section and Associate Chief of Staff for Ambulatory Care at the Dallas Veterans Administration Medical Center. He is board certified in internal medicine, hematology and medical oncology.
More
Oncology Resource Networks
We develop and implement programs that improve practice performance and can support your success in OCM’s value-based payment model.
Advisory Team
ORN has assembled an Advisory Board with representation from across the clinical practice of oncology, different stakeholders in the broader system of care, academic and analytic experts, and both public and private payers. Our board members advise on business strategy, provide clinical thought leadership, make strategic connections, and in some cases partner with us on specific programs.
Scott Gottlieb, MD
Advisor
Scott is former Deputy Commissioner of the FDA, a physician and Resident Fellow at the American Enterprise Institute. A leading expert in health policy, Dr. Gottlieb’s work focuses on providing insights into the economic and technological forces driving the transformation of healthcare. He is a frequent contributor to national publications, including Forbes and The Wall Street Journal.
Jason Fisherman, MD, MBA
Advisor
Jason is Co-founder of Synthesis Capital since 2007. Dr. Fisherman focuses on healthcare, information technologies, life science, biopharmaceutical, and medical technology industries.
Kjel A. Johnson, PharmD, BCPS, FCCP, FAMCP
Advisor
Kjel is the Vice President of Global Oncology for IMS Health, where he manages the oncology data, analytics, and informatics business across thirteen key geographies. Prior to IMS Health, he was the Senior Vice President of Strategy and Business Development at Magellan Pharmacy Services / ICORE Healthcare.